Academic literature on the topic 'Mucosal biofilms'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Mucosal biofilms.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Mucosal biofilms"
1
Diaz, Patricia I., Zhihong Xie, Takanori Sobue, Angela Thompson, Basak Biyikoglu, Austin Ricker, Laertis Ikonomou, and Anna Dongari-Bagtzoglou. "Synergistic Interaction between Candida albicans and Commensal Oral Streptococci in a NovelIn VitroMucosal Model." Infection and Immunity 80, no. 2 (November 21, 2011): 620–32. http://dx.doi.org/10.1128/iai.05896-11.
Full textAbstract:
ABSTRACTCandida albicansis a commensal colonizer of the gastrointestinal tract of humans, where it coexists with highly diverse bacterial communities. It is not clear whether this interaction limits or promotes the potential ofC. albicansto become an opportunistic pathogen. Here we investigate the interaction betweenC. albicansand three species of streptococci from the viridans group, which are ubiquitous and abundant oral commensal bacteria. The ability ofC. albicansto form biofilms withStreptococcus oralis,Streptococcus sanguinis, orStreptococcus gordoniiwas investigated using flow cell devices that allow abiotic biofilm formation under salivary flow. In addition, we designed a novel flow cell system that allows mucosal biofilm formation under conditions that mimic the environment in the oral and esophageal mucosae. It was observed thatC. albicansand streptococci formed a synergistic partnership whereC. albicanspromoted the ability of streptococci to form biofilms on abiotic surfaces or on the surface of an oral mucosa analogue. The increased ability of streptococci to form biofilms in the presence ofC. albicanscould not be explained by a growth-stimulatory effect since the streptococci were unaffected in their growth in planktonic coculture withC. albicans. Conversely, the presence of streptococci increased the ability ofC. albicansto invade organotypic models of the oral and esophageal mucosae under conditions of salivary flow. Moreover, characterization of mucosal invasion by the biofilm microorganisms suggested that the esophageal mucosa is more permissive to invasion than the oral mucosa. In summary,C. albicansand commensal oral streptococci display a synergistic interaction with implications for the pathogenic potential ofC. albicansin the upper gastrointestinal tract.
2
Kleessen, Brigitta, and Michael Blaut. "Modulation of gut mucosal biofilms." British Journal of Nutrition 93, S1 (April 2005): S35—S40. http://dx.doi.org/10.1079/bjn20041346.
Full textAbstract:
Non-digestible inulin-type fructans, such as oligofructose and high-molecular-weight inulin, have been shown to have the ability to alter the intestinal microbiota composition in such a way that members of the microbial community, generally considered as health-promoting, are stimulated. Bifidobacteria and lactobacilli are the most frequently targeted organisms. Less information exists on effects of inulin-type fructans on the composition, metabolism and healthrelated significance of bacteria at or near the mucosa surface or in the mucus layer forming mucosa-associated biofilms. Using rats inoculated with a human faecal flora as an experimental model we have found that inulin-type fructans in the diet modulated the gut microbiota by stimulation of mucosa-associated bifidobacteria as well as by partial reduction of pathogenicSalmonella enterica subsp. entericaserovar Typhimurium and thereby benefit health. In addition to changes in mucosal biofilms, inulin-type fructans also induced changes in the colonic mucosa stimulating proliferation in the crypts, increasing the release of mucins, and altering the profile of mucin components in the goblet cells and epithelial mucus layer. These results indicate that inulin-type fructans may stabilise the gut mucosal barrier. Dietary supplementation with these prebiotics could offer a new approach to supporting the barrier function of the mucosa.
3
Gupta, Neelima, PP Singh, Lakshmi Vaid, Manish Arya, and Rumpa Saha. "Impact of Biofilms on Quality of Life of Rhinosinusitis Patients after Endoscopic Sinus Surgery." An International Journal Clinical Rhinology 5, no. 3 (2012): 95–102. http://dx.doi.org/10.5005/jp-journals-10013-1127.
Full textAbstract:
ABSTRACT Introduction The chronic and recalcitrant nature of rhinosinusitis has been known from many years. Many reasons for this have been implicated and biofilms have now been established as one of the cause for its recurrent and persistent nature. Little literature and studies exist confirming this effect. This study presents analysis of sinonasal mucosal samples and correlates presence of biofilms with surgical outcomes. Materials and methods An analysis of mucosal samples collected during endoscopic sinus surgery from 40 patients of chronic rhinosinusitis (CRS) was done. Preoperative symptoms, endoscopic and radiological scores were documented and mucosal samples collected intraoperatively were sent for biofilm detection. Biofilm detection was performed using microtiter plate method. Postoperatively patients were followed up for minimum of 3 months with endoscopic evaluation and presence of ongoing symptoms was also recorded. Results Thirteen patients out of 40 patients showed positive bacterial culture. Eight out of 13, i.e. 61.53% bacteria produced biofilms and five out of 13, i.e. 38.46% bacteria did not produce biofilms. Patients with biofilms had significantly worse preoperative and postoperative symptom and endoscopic scores. Thus, presence of biofilms was related to poor outcomes. Conclusion This study showed that the presence of biofilms was correlated with higher symptom scores and poorer surgical outcomes. Also, more recurrences were found in patients with positive biofilms. This strengthens the belief that biofilms may play an active role in persisting mucosal inflammation and persistent symptoms in some patients of CRS. Treatment modalities aiming removal of biofilms may be important in management of CRS. How to cite this article Vaid L, Arya M, Gupta N, Singh PP, Saha R. Impact of Biofilms on Quality of Life of Rhinosinusitis Patients after Endoscopic Sinus Surgery. Clin Rhinol An Int J 2012;5(3):95-102.
4
Zhang, Zi, Demin Han, Shengzhong Zhang, Yehua Han, Wei Dai, Erzhong Fan, Ying Li, Yunchuan Li, and Deyun Wang. "Biofilms and Mucosal Healing in Postsurgical Patients with Chronic Rhinosinusitis." American Journal of Rhinology & Allergy 23, no. 5 (September 2009): 506–11. http://dx.doi.org/10.2500/ajra.2009.23.3376.
Full textAbstract:
Background Patients with chronic rhinosinusitis (CRS) often remain symptomatic after technically proficient functional endoscopic sinus surgery. Current hypothesis indicates biofilms may contribute to the persistence of infection. However, few studies showed biofilms in postoperative patients. This study was designed to identify bacterial biofilms on postoperative mucosa, as well as to investigate the healing of sinus mucosa after surgery. Methods After intraoperative mucosa was obtained for assessment of biofilms, 27 patients were followed up for 6 months. Postoperative medications and symptoms were recorded. As indicated by endoscopic evaluation, biopsy specimens of postoperative edema, scar, or adhesion were obtained. Samples were prepared for scanning electron microscopy (SEM) and hematoxylin and eosin (H&E) staining. Results Fifteen postoperative samples were taken from the 20 patients with intraoperative biofilms. Under SEM, postoperative biofilms were identified in 4/6 scar samples and 5/9 edema samples. There was no significant difference in biofilm presence between samples of scar and edema. Microcolonies were also identified on postoperative scar under H&E staining. The presence of intraoperative and postoperative biofilms was correlated with the severity of preoperative Lund-MacKay computed tomography score and postoperative Lund-Kennedy endoscopic score. Compared with intraoperative samples, postoperative samples from the same nine patients significantly recovered from ciliary damage, metaplasia, and basement membrane thickness. Postoperative cultures were positive in samples with and without postoperative biofilms. Conclusion Biofilms persist after treatment, and may cause the unfavorable outcomes of surgery for CRS. The mucosa with biofilms can recover after surgery. Apparent bacterial plaque can be identified by H&E staining.
5
Sutar, Yogesh, Sunna Nabeela, Shakti Singh, Abdullah Alqarihi, Norma Solis, Teklegiorgis Ghebremariam, Scott Filler, Ashraf S. Ibrahim, Abhijit Date, and Priya Uppuluri. "Niclosamide-loaded nanoparticles disrupt Candida biofilms and protect mice from mucosal candidiasis." PLOS Biology 20, no. 8 (August 17, 2022): e3001762. http://dx.doi.org/10.1371/journal.pbio.3001762.
Full textAbstract:
Candida albicans biofilms are a complex multilayer community of cells that are resistant to almost all classes of antifungal drugs. The bottommost layers of biofilms experience nutrient limitation where C. albicans cells are required to respire. We previously reported that a protein Ndu1 is essential for Candida mitochondrial respiration; loss of NDU1 causes inability of C. albicans to grow on alternative carbon sources and triggers early biofilm detachment. Here, we screened a repurposed library of FDA-approved small molecule inhibitors to identify those that prevent NDU1-associated functions. We identified an antihelminthic drug, Niclosamide (NCL), which not only prevented growth on acetate, C. albicans hyphenation and early biofilm growth, but also completely disengaged fully grown biofilms of drug-resistant C. albicans and Candida auris from their growth surface. To overcome the suboptimal solubility and permeability of NCL that is well known to affect its in vivo efficacy, we developed NCL-encapsulated Eudragit EPO (an FDA-approved polymer) nanoparticles (NCL-EPO-NPs) with high niclosamide loading, which also provided long-term stability. The developed NCL-EPO-NPs completely penetrated mature biofilms and attained anti-biofilm activity at low microgram concentrations. NCL-EPO-NPs induced ROS activity in C. albicans and drastically reduced oxygen consumption rate in the fungus, similar to that seen in an NDU1 mutant. NCL-EPO-NPs also significantly abrogated mucocutaneous candidiasis by fluconazole-resistant strains of C. albicans, in mice models of oropharyngeal and vulvovaginal candidiasis. To our knowledge, this is the first study that targets biofilm detachment as a target to get rid of drug-resistant Candida biofilms and uses NPs of an FDA-approved nontoxic drug to improve biofilm penetrability and microbial killing.
6
Chassaing, Benoit, Estelle Garénaux, Jessica Carriere, Nathalie Rolhion, Yann Guérardel, Nicolas Barnich, Richard Bonnet, and Arlette Darfeuille-Michaud. "Analysis of the σERegulon in Crohn's Disease-Associated Escherichia coli Revealed Involvement of thewaaWVLOperon in Biofilm Formation." Journal of Bacteriology 197, no. 8 (February 9, 2015): 1451–65. http://dx.doi.org/10.1128/jb.02499-14.
Full textAbstract:
ABSTRACTIleal lesions of patients with Crohn's disease are colonized by adherent-invasiveEscherichia coli(AIEC), which is able to adhere to and to invade intestinal epithelial cells (IEC), to replicate within macrophages, and to form biofilms on the surface of the intestinal mucosa. Previous analyses indicated the involvement of the σEpathway in AIEC-IEC interaction, as well as in biofilm formation, with σEpathway inhibition leading to an impaired ability of AIEC to colonize the intestinal mucosa and to form biofilms. The aim of this study was to characterize the σEregulon of AIEC strain LF82 in order to identify members involved in AIEC phenotypes. Using comparativein silicoanalysis of the σEregulon, we identified thewaaWVLoperon as a new member of the σEregulon in reference AIEC strain LF82. We determined that thewaaWVLoperon is involved in AIEC lipopolysaccharide structure and composition, and thewaaWVLoperon was found to be essential for AIEC strains to produce biofilm and to colonize the intestinal mucosa.IMPORTANCEAn increased prevalence of adherent-invasiveEscherichia coli(AIEC) bacteria was previously observed in the intestinal mucosa of Crohn's disease (CD) patients, and clinical observations revealed bacterial biofilms associated with the mucosa of CD patients. Here, analysis of the σEregulon in AIEC and commensalE. coliidentified 12 genes controlled by σEonly in AIEC. Among them, WaaWVL factors were found to play an essential role in biofilm formation and mucosal colonization by AIEC. In addition to identifying molecular tools that revealed a pathogenic population ofE. colicolonizing the mucosa of CD patients, these results indicate that targeting thewaaWVLoperon could be a potent therapeutic strategy to interfere with the ability of AIEC to form biofilms and to colonize the gut mucosa.
7
Keir, J., L. Pedelty, and A. C. Swift. "Biofilms in chronic rhinosinusitis: systematic review and suggestions for future research." Journal of Laryngology & Otology 125, no. 4 (February 11, 2011): 331–37. http://dx.doi.org/10.1017/s0022215111000016.
Full textAbstract:
AbstractBackground:A biofilm is a community of micro-organisms encased within a self-produced, extracellular, polymeric substance. The role of biofilms as a major pathological aetiology in chronic rhinosinusitis would help explain the clinical manifestation of the disease.Objectives:To examine the current evidence, and to discuss possible future research directions, in relation to biofilms and chronic rhinosinusitis.Study design:Systematic literature review.Evaluation method:Two assessors independently undertook critical appraisal of the studies identified by the literature search. Significant findings were incorporated into this review. The primary outcome assessed was the presence of biofilm in human mucosal biopsy samples taken from patients with chronic rhinosinusitis, and from healthy controls.Results:We identified 11 studies examining biofilm formation in human mucosal biopsy samples taken from patients with chronic rhinosinusitis.Conclusion:It is unlikely that biofilms occur in every case of chronic rhinosinusitis; consequently, the significance of ‘biofilm detection’ in some series should be considered carefully. Several authors have argued strongly for the use of confocal scanning laser microscopy with fluorescent in situ hybridisation probes as the ‘gold standard’ for biofilm imaging. This imaging modality should be combined with further investigation of the microbiology of chronic rhinosinusitis, and of the efficacy of traditional culture techniques used for pathogen identification.
8
Ganguly, Shantanu, and Aaron P. Mitchell. "Mucosal biofilms of Candida albicans." Current Opinion in Microbiology 14, no. 4 (August 2011): 380–85. http://dx.doi.org/10.1016/j.mib.2011.06.001.
Full text
9
McCullough, M., L. L. Patton, M. Coogan, P. L. Fidel, M. Komesu, M. Ghannoum, and J. E. Leigh. "New Approaches to Candida and Oral Mycotic Infections." Advances in Dental Research 23, no. 1 (March 25, 2011): 152–58. http://dx.doi.org/10.1177/0022034511400912.
Full textAbstract:
This workshop reviewed aspects of the following: oral fungal disease in HIV-infected patients and the predictive value of oral mucosal disease in HIV progression; the role of the oral biofilms in mucosal disease; microbial virulence factors and the pseudomembranous oral mucosal disease process; the role that oral mucosal disease may have in HIV transmission; and the available topical antifungal treatment. This article summarizes the ensuing discussions and raises pertinent problems and potential research directions associated with oral fungal disease in HIV-infected patients, including the frequency of oral candidosis, the role of the intraoral biofilm in the development of oral mucosal disease, and host-pathogen interactions, as well as the development of the fetal oral mucosa, neonatal nutrition, and the role of oral candidosis in this setting. Finally, discussions are summarized on the use of inexpensive effective antifungal mouthwashes in resource-poor countries, the potential stigmata that may be associated with their use, as well as novel topical medications that may have clinical applicability in managing oral candidal infections in HIV-infected patients.
10
Meza-Torres, Jazmin, Emile Auria, Bruno Dupuy, and Yannick D. N. Tremblay. "Wolf in Sheep’s Clothing: Clostridioides difficile Biofilm as a Reservoir for Recurrent Infections." Microorganisms 9, no. 9 (September 10, 2021): 1922. http://dx.doi.org/10.3390/microorganisms9091922.
Full textAbstract:
The microbiota inhabiting the intestinal tract provide several critical functions to its host. Microorganisms found at the mucosal layer form organized three-dimensional structures which are considered to be biofilms. Their development and functions are influenced by host factors, host-microbe interactions, and microbe-microbe interactions. These structures can dictate the health of their host by strengthening the natural defenses of the gut epithelium or cause disease by exacerbating underlying conditions. Biofilm communities can also block the establishment of pathogens and prevent infectious diseases. Although these biofilms are important for colonization resistance, new data provide evidence that gut biofilms can act as a reservoir for pathogens such as Clostridioides difficile. In this review, we will look at the biofilms of the intestinal tract, their contribution to health and disease, and the factors influencing their formation. We will then focus on the factors contributing to biofilm formation in C. difficile, how these biofilms are formed, and their properties. In the last section, we will look at how the gut microbiota and the gut biofilm influence C. difficile biofilm formation, persistence, and transmission.
Dissertations / Theses on the topic "Mucosal biofilms"
1
Belato, Kely Karina [UNESP]. "Análise in vitro da atividade antimicrobiana, citotoxicidade e genotoxicidade de um princípio ativo (Timol) e de um enxaguatório bucal (LISTERINE® ZERO™)." Universidade Estadual Paulista (UNESP), 2014. http://hdl.handle.net/11449/123728.
Full textAbstract:
Made available in DSpace on 2015-06-17T19:33:46Z (GMT). No. of bitstreams: 0
Previous issue date: 2014-12-15. Added 1 bitstream(s) on 2015-06-18T12:48:04Z : No. of bitstreams: 1
000827368.pdf: 472014 bytes, checksum: 9454895a0e77c23b547713df1dc6e3fc (MD5)Este estudo se propôs a avaliar a atividade antimicrobiana do princípio ativo Timol e de um enxaguatório bucal (LISTERINE® ZEROTM) sobre Candida albicans, Staphylococcus aureus e Streptococcus mutans e também sua citotoxicidade e genotoxicidade em culturas de macrófagos (RAW 264.7). Após determinação da Concentração Inibitória Mínima (CIM) e da Concentração Microbicida Mínima (CMM) pelo método de microdiluição em caldo do extrato foi avaliada a ação antimicrobiana do Timol e do LISTERINE® ZEROTM em biofilme. A citotoxicidade do Timol e do LISTERINE® ZEROTM foi avaliada sobre as células pelo método MTT e também pela quantificação de TNF-α pelo método imunoenzimático ELISA. Ainda, a genotoxicidade foi determinada pela formação de micronúcleos nas células após 24 h de exposição ao Timol e 1min ao LISTERINE® ZEROTM e ao etilmetano sulfanato (controle positivo). Os dados foram avaliados pelos testes estatísticos ANOVA e complementado pelo teste de Tukey e Kruskal Wallis (nível de significância de 5%). Obtivemos resultados favoráveis quanto a ação antimicrobiana do princípio ativo para os micro-organismos testados sendo a CMM de 160 μg mL-1 eficaz para S. mutans e S. aureus e de 80 μg mL-1 para C. albicans, para LISTERINE® ZEROTM foi eficaz na concentração de 0, 3125 μg mL-1, em biofilme apresentou média de 1,85 ± 0,14 para Timol em S. mutans, 1,90 ± 0,07 para S. aureus e 6,66 ± 0,17 para C. albicans. A citotoxicidade do Timol foi observada acima de 5 μg mL-1, e o LISTERINE® ZEROTM foi tóxico para as células; quanto a genotoxicidade não foi observado dano ao nível de DNA. Desta forma concluímos que o princípio ativo Timol, possui ação antimicrobiana em concentrações mais elevadas, no entanto que nestas concentrações possui alta toxicidade celular, e o LISTERINE® ZEROTM possui ação antimicrobiana na menor concentração testada e é citotóxico
This study aimed to evaluate the antimicrobial activity of the active ingredient thymol and a mouthwash (LISTERINE® ZEROTM) on Candida albicans, Staphylococcus aureus and Streptococcus mutans and also their cytotoxicity and genotoxicity in macrophage cultures (RAW 264.7). After determining the minimum inhibitory concentration (MIC) and Minimum Concentration Microbicide (CMM) by microdilution broth method extract was evaluated the antimicrobial action of thymol and LISTERINE® ZEROTM n biofilm. The cytotoxicity of thymol and LISTERINE® ZEROTM on the cells was evaluated by MTT method and also by quantifying TNF-α by ELISA immunoenzymatic method. Further, genotoxicity is determined by the formation of micronuclei in cells after 24 h of exposure to thymol and the LISTERINE® ZEROTM 1min and ethylmethane sulfonate (positive control). Data were analyzed by ANOVA and Tukey complemented by test and Kruskal Wallis (5% significance level). We obtained favorable results regarding the antimicrobial action of the active ingredient for the microorganisms tested with the CMM 160 mg L-1 effective for S. mutans and S. aureus and 80 mg L-1 for C. albicans to LISTERINE® ZEROTM was effective at levels of 0, 3125 mg L-1, biofilm had a mean of 1.85 ± 0.14 for thymol in S. mutans, 1.90 ± 0.07 to 6.66 ± S. aureus and 0, 17 for C. albicans. The cytotoxicity of thymol was observed above 5 mg L-1, and LISTERINE® ZEROTM was toxic to cells; as genotoxic damage was not observed at the level of DNA. Thus we conclude that the active ingredient thymol, has antimicrobial action in higher concentrations, however that these concentrations has high cellular toxicity, and the LISTERINE® ZEROTM has antimicrobial action in the smallest concentration tested and is cytotoxic
2
Belato, Kely Karina. "Análise in vitro da atividade antimicrobiana, citotoxicidade e genotoxicidade de um princípio ativo (Timol) e de um enxaguatório bucal (LISTERINE® ZERO™)." São José dos Campos, 2014, 2014. http://hdl.handle.net/11449/123728.
Full textAbstract:
Orientador: Samira Esteves Afonso CamargoCo-orientador: Luciane Dias de Oliveira
Banca: Graziella Nuernberg Back Brito
Banca: Paula Elaine Cardoso
Resumo: Este estudo se propôs a avaliar a atividade antimicrobiana do princípio ativo Timol e de um enxaguatório bucal (LISTERINE® ZEROTM) sobre Candida albicans, Staphylococcus aureus e Streptococcus mutans e também sua citotoxicidade e genotoxicidade em culturas de macrófagos (RAW 264.7). Após determinação da Concentração Inibitória Mínima (CIM) e da Concentração Microbicida Mínima (CMM) pelo método de microdiluição em caldo do extrato foi avaliada a ação antimicrobiana do Timol e do LISTERINE® ZEROTM em biofilme. A citotoxicidade do Timol e do LISTERINE® ZEROTM foi avaliada sobre as células pelo método MTT e também pela quantificação de TNF-α pelo método imunoenzimático ELISA. Ainda, a genotoxicidade foi determinada pela formação de micronúcleos nas células após 24 h de exposição ao Timol e 1min ao LISTERINE® ZEROTM e ao etilmetano sulfanato (controle positivo). Os dados foram avaliados pelos testes estatísticos ANOVA e complementado pelo teste de Tukey e Kruskal Wallis (nível de significância de 5%). Obtivemos resultados favoráveis quanto a ação antimicrobiana do princípio ativo para os micro-organismos testados sendo a CMM de 160 μg mL-1 eficaz para S. mutans e S. aureus e de 80 μg mL-1 para C. albicans, para LISTERINE® ZEROTM foi eficaz na concentração de 0, 3125 μg mL-1, em biofilme apresentou média de 1,85 ± 0,14 para Timol em S. mutans, 1,90 ± 0,07 para S. aureus e 6,66 ± 0,17 para C. albicans. A citotoxicidade do Timol foi observada acima de 5 μg mL-1, e o LISTERINE® ZEROTM foi tóxico para as células; quanto a genotoxicidade não foi observado dano ao nível de DNA. Desta forma concluímos que o princípio ativo Timol, possui ação antimicrobiana em concentrações mais elevadas, no entanto que nestas concentrações possui alta toxicidade celular, e o LISTERINE® ZEROTM possui ação antimicrobiana na menor concentração testada e é citotóxico
Abstract: This study aimed to evaluate the antimicrobial activity of the active ingredient thymol and a mouthwash (LISTERINE® ZEROTM) on Candida albicans, Staphylococcus aureus and Streptococcus mutans and also their cytotoxicity and genotoxicity in macrophage cultures (RAW 264.7). After determining the minimum inhibitory concentration (MIC) and Minimum Concentration Microbicide (CMM) by microdilution broth method extract was evaluated the antimicrobial action of thymol and LISTERINE® ZEROTM n biofilm. The cytotoxicity of thymol and LISTERINE® ZEROTM on the cells was evaluated by MTT method and also by quantifying TNF-α by ELISA immunoenzymatic method. Further, genotoxicity is determined by the formation of micronuclei in cells after 24 h of exposure to thymol and the LISTERINE® ZEROTM 1min and ethylmethane sulfonate (positive control). Data were analyzed by ANOVA and Tukey complemented by test and Kruskal Wallis (5% significance level). We obtained favorable results regarding the antimicrobial action of the active ingredient for the microorganisms tested with the CMM 160 mg L-1 effective for S. mutans and S. aureus and 80 mg L-1 for C. albicans to LISTERINE® ZEROTM was effective at levels of 0, 3125 mg L-1, biofilm had a mean of 1.85 ± 0.14 for thymol in S. mutans, 1.90 ± 0.07 to 6.66 ± S. aureus and 0, 17 for C. albicans. The cytotoxicity of thymol was observed above 5 mg L-1, and LISTERINE® ZEROTM was toxic to cells; as genotoxic damage was not observed at the level of DNA. Thus we conclude that the active ingredient thymol, has antimicrobial action in higher concentrations, however that these concentrations has high cellular toxicity, and the LISTERINE® ZEROTM has antimicrobial action in the smallest concentration tested and is cytotoxic
Mestre
3
Bezerra, Thiago Freire Pinto. "O papel do biofilme na rinossinusite crônica com polipose nasossinusal." Universidade de São Paulo, 2012. http://www.teses.usp.br/teses/disponiveis/5/5143/tde-01082012-135039/.
Full textAbstract:
Introdução: A patogenia da rinossinusite crônica com polipose nasossinusal não está completamente estabelecida e existem algumas explicações para essa doença como os superantigenos, o desequilíbrio inflamatório e, mais recentemente, o biofilme. Objetivos: Avaliar a associação entre a presença do biofilme e a presença de rinossinusite crônica com polipose nasossinusal. Avaliar o quadro clínico e radiológico pré-operatória e pós-operatória segundo a presença do biofilme. Métodos: Este é uma estudo realizado em um hospital terciário universitário. A primeira parte foi um estudo caso-controle com um grupo de 33 pacientes consecutivos com rinossinusite crônica com polipose nasossinusal submetidos a cirurgica endoscópica nasossinusal e um grupo controle de 27 pacientes submetidos a septoplastia para tratamento de obstrução nasal. As amostras da mucosa foram coletadas no intra-operatório para avaliação por microscopia eletrônica de varredura para determinar a presença do biofilme. A segunda parte foi um estudo prospectivo em que dados pré-operatórios e pós-operatórios foram registrados, incluindo avaliações padronizadas da qualidade de vida doença-específica relacionadas à obstrução nasal e à rinossinusite, da endoscopia nasal e da tomografia de cavidades paranasais. A análise estatísca foi realizada. Para todos os testes um p=0.05 foi considerado significativo. Resultados: Os biofilmes foram encontrados em 72.7% (24/33) dos pacientes com rinossinusite crônica com polipose nasossinusal e 48.1% (13/27) dos pacientes submetidos a septoplastia (Odd ratio=2.87, IC95% 0.9796-8.419, p=0.051). Este foi o primeiro estudo a analisar o efeito da presença do biofilme nos resultados pós-operatórios com medidas padronizadas de um grupo de pacientes apenas com rinossinusite crônica com polipose nasossinusal. O biofilme estava presente em 72.4% (21/29) dos pacientes que completaram o seguimento. Os pacientes com biofilmes apresentaram uma pior pontuação pré-operatória NOSE e Lund-Kennedy estatísticamente significativos, mas uma mediana semelhante na pontuação total do SNOT-20. Os pacientes com biofilme apresentaram uma melhor resultado na pontuação Lund-Kennedy (p=0.036). Estes pacientes apresentaram piores resultados no SNOT-20 e resultados similares quanto ao NOSE e o Lund-Mackay. Conclusão: Os biofilmes foram demonstrados presentes nos pacientes submetidos a cirurgia endoscópica funcional para rinossinusite crônica com polipose nasossinusal mas também nos controles. Embora a prevalência não tenha sido diferente significativamente, o intervalo de confiança extremamente amplo de 95%, que apenas cruza a unidade, sugere que uma diferença significativa pode ter sido perdida por causa do baixo poder estatístico e estudos futuros serão necessários. Os biofilmes estiveram relacionados com pior qualidade de vida doença-específica pré-operatória NOSE e avaliação endoscópica (Lund-Kennedy), e melhores resultados endoscópicos. Nossos resultados sugerem que nos pacientes com uma melhora clínica significativa após a cirurgia, o biofilme representou um papel mais predominante na fisiopatologia da doença. Neste subgrupo, a cirurgia provavelmente removeu a quantidade de biofilme necessária para restaurar o desequilíbrio inflamatório na mucosaIntroduction: The pathogenesis of chronic rhinosinusitis with nasal polyps is not completely established and there are some explanations for this disease, such as superantigens, inflammatory imbalance and, more recently, biofilms. Objective: Evaluate the association of biofilms presence and chronic rhinosinusitis with nasal polyps. Evaluate outcomes after sinus surgery for chronic rhinosinusitis with nasal polyps according to the presence of biofilms. Methods: This is a University based-tertiary care center study. The first part was a case-control study that evaluated a group of 33 consecutive patients undergoing functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps and a control group of 27 patients undergoing septoplasty for nasal obstruction treatment. Mucosal samples were harvested intra-operatively for scanning electron microscopic examination to determine biofilms presence. The second part was a prospective study. Preoperative and follow up data were recorded, including standardized evaluations of disease-specific quality of life related to nasal obstruction and rhinosinusitis, of nasal endoscopy and sinus computer tomography scan. Statistical analysis was performed. For all statistical tests p=0.05 was considered significant. Results: Biofilms were found in 72.7% (24/33) of chronic rhinosinusitis with nasal polyps patients and in 48.1%(13/27) of septoplasty patients (Odds ratio = 2.87, CI95% from 0.9796 to 8.419, p=0.051). This was the first report to analyze the effect of biofilms in outcomes with standardized measures of a group of only chronic rhinosinusitis with nasal polyps patients. Biofilms were present in 72.4% (21/29) of these patients. Patients with biofilms had a statistically significant worst preoperative score related to nasal obstruction and nasal endoscopy, but a similar median sinusitis total score. Patients with biofilms presented better Lund-Kennedy outcome (-3[5]vs.-1[2],U=46.0,p=0.036), but the best endoscopic improvement might reflect the worst clinical preoperative status. These patients had worst outcomes in SNOT-20 (-0.75[1.15]vs.-1.30[1.32],U=69.0,p=0.21) and similar outcomes in NOSE(-55.0[50.0] vs. -60.0[50.0], U=81.0,p=0.67) and Lund-Mackay (-4[5]vs.-4[4]),U=75.5,p=0.49). Patients with biofilms presented better Lund-Kennedy outcome (p=0.036). There was a correlation among some QoL outcome scores in both groups. Conclusion: Biofilms were demonstrated to be present in patients undergoing functional endoscopic sinus surgery for chronic rhinosinusitis with nasal polyps but also in controls. Although the prevalence was not significantly different, the extremely wide 95% confidence interval, which just crosses unity, suggests that a meaningful clinical difference may have been missed because of low statistical power and that further study is necessary. Biofilms were related with worst preoperative disease-specific quality of life questionnaire (NOSE) and endoscopic evaluation (Lund-Kennedy), and better endoscopic outcome. Our findings suggest that in patients with a significant clinical improvement after surgery, the biofilm had a more predominant role in the pathophysiology of the disease. In this subgroup, the surgery probably removed the amount of biofilms needed to restore the mucosal inflammatory imbalance
4
Bertolini, Martinna de Mendonça e. 1986. "Condições de crescimento influenciam as características estruturais e de virulência de biofilmes de Candida e Streptococcus formados sobre modelos in vitro de mucosa oral humana = Growth conditions influence at strutural and virulence characterístics of Candida and Streptococcus biofilms developed on in vitro models of human oral mucosa." [s.n.], 2015. http://repositorio.unicamp.br/jspui/handle/REPOSIP/287968.
Full textAbstract:
Orientador: Altair Antoninha Del Bel CuryTese (doutorado) - Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba
Made available in DSpace on 2018-08-26T14:52:55Z (GMT). No. of bitstreams: 1 Bertolini_MartinnadeMendoncae_D.pdf: 3303888 bytes, checksum: 17ca780a99a3e63d87bcf4ed94370ffc (MD5) Previous issue date: 2015
Resumo: O patógeno oportunista Candida albicans e Streptococcus do grupo Mitis formam comunidades complexas em múltiplos sítios da cavidade oral, nos quais o ambiente e a disponibilidade de nutrientes sofrem mudanças constantes. Objetivou-se estudar as características estruturais e de virulência de biofilmes de Candida albicans na presença e ausência de S. oralis crescendo sobre um modelo tri dimensional de mucosa oral humana, em diferentes condições: (1) umidade da superfície mucosa (molhada ou semi seca), (2) disponibilidade de nutrientes (suplementação do meio de cultura com BHI) e (3) morfotipo da hifa (hifa ou pseudo hifa). Para isso foram utilizados modelos tri dimensionais de mucosa oral humana formado por queratinócitos imortalizados (linhagens celulares OKF6-TERT2 ou SCC15) sobre uma matriz colágena com fibroblastos para o crescimento dos biofilmes. Estes foram infectados por Streptococcus oralis 34, e/ou Candida albicans, sendo uma cepa de referência e cepas mutantes para a formação de pseudo-hifas, pela deleção dos genes ndt80 ou tup1. A determinação do biovolume e estrutura do biofilme foram realizadas por microscopia confocal a laser, com os biofilmes sendo corados por imunofluorescência com anticorpo especifico para C. albicans e sonda para Streptococcus. Como determinante de virlência secções de tecido com 5 ?m de espessura foram coradas da mesma maneira anterior ou por hematoxilina e eosina, com o intuito de se detectar a invasão de microorganismos. O dano tecidual também foi mensurado pela liberação de lactato desicrogenase no meio de cultura. Os dados foram avaliados por análises de variâncias (ANOVA) e os procedimentos para comparações múltiplas pareadas por Bonferroni t-test, com ? = 5%. Em condições úmidas C. albicans estendeu hifas longas e entrelaçadas, formando um biofilme de superfície homogênea. Biofilmes mistos apresentaram uma estrutura estratificada, com S. oralis crescendo em contato com a mucosa e a C. albicans cobrindo a superfície bacteriana. Em condições de semi-secas a C. albicans formou densos focos de crescimento localizados a partir dos quais as hifas estenderam-se radialmente para se entrelaçarem com hifas de focos adjacentes. Em biofilmes mistos este fenômeno provocou o acúmulo focal de S. oralis co-localizado com os focos de C. albicans. Embora o biovolume do biofilme de C. albicans tenha sido significativamente maior em condições úmidas (P<0,001), houve uma invasão tecidual mínima em comparação com as condições semi-secas, na qual a barreira epitelial foi completamente destruída. A suplementação do meio de cultura, em condições semi-secas não alterou a arquitetura do biofilme, mas intensificaram o crescimento, o biovolume e a invasão/dano tecidual (P<0,001), proporcionalmente as concentrações testadas. Mutantes para a formação de pseudo-hifas formaram biofilmes defeituosos, nos quais a maioria dos S. oralis estava em contato com a superfície epitelial, abaixo das pseudo-hifas. A presença de S. oralis promoveu invasão e dano tecidual em todas as condições. Conclui-se que a umidade, a disponibilidade de nutrientes, o morfotipo da Candida e a presença de S. oralis afetam fortemente a arquitetura e virulência de biofilmes de C. albicans crescidos sobre nas mucosas
Abstract: The opportunistic pathogen Candida albicans and streptococci of the Mitis group form complex communities in multiple oral sites, where the environment and nutrient availability change constantly. We aimed to study structural and virulence characteristics of Candida albicans biofilms in the presence or absence of S. oralis, growing on a three-dimensional model of human oral mucosa, under different conditions: (1) moisture of mucosal surface (wet or semi dry), (2) nutrient availability (BHI supplementation on culture media) and (3) hyphal morphotype (hyphae or pseudohyphae). For this it was used a three-dimensional model of the human oral mucosa formed by immortalized oral keratinocytes (OKF6-TERT2 or SCC15 cell lines) on a fibroblast-embedded collagenous matrix to grow biofilms. Infections were carried out using Streptococcus oralis 34, a C. albicans reference strain and pseudohyphal mutants with a homozygous deletion of the ndt80, or tup1 gene. Determination of biofilm biovolume and structure was done by confocal scanning laser microscopy with biofilms stained by immunofluorescence using an anti-Candida antibody and a Streptococcus probe. As determinant of virulence, 5-?m-thick tissue sections were stained same way or with hematoxylin and eosin in order to detect invasion of microorganisms. Also tissue damage was measured by lactate dehydrogenase release in the culture media. Statistical analyses were performed using SigmaPlot 12 software at 5% significance level. Data were evaluated by analysis of variance (ANOVA) and when statistical significances were found, all pairwise multiple comparison procedures were performed with Bonferroni t-test, with ? = 5%. Under wet conditions C. albicans extended long intertwined hyphae, forming a homogeneous surface biofilm. Mixed biofilms had a stratified structure, with S. oralis growing in close contact to the mucosa and C. albicans growing on the bacterial surface. Under semi-dry conditions, C. albicans formed localized foci of dense growth from which hyphae extended radially to intertwine with hyphae from adjacent foci. In mixed biofilms this promoted focal growth of S. oralis co-localizing with C. albicans. Although Candida biofilm biovolume was significantly greater under wet conditions (P<0.001), there was minimal tissue invasion compared to semidry conditions where the epithelial barrier was completely destroyed. Supplementing the infection medium with nutrients under semidry conditions did not change the biofilm architecture but intensified focal growth and increased biofilm biovolume and tissue invasion/damage (P<0.001), proportionally to the tested concentrations. Pseudohyphal mutants formed defective mixed biofilms, with most S. oralis in contact with the epithelial surface, below the pseudohyphal mass. Interestingly, the presence of S. oralis promoted fungal invasion and tissue damage under all conditions. Moisture, nutrient availability, hyphal morphotype and presence of S. oralis strongly affect architecture and virulence of mucosal fungal biofilms
Doutorado
Protese Dental
Doutora em Clínica Odontológica
5
Dias, Kássia de Carvalho. "Efeito das toxinas microbianas provenientes de biofilme simples ou misto de Staphylococcus aureus e Candida albicans sobre monoculturas ou culturas 3D de células da mucosa oral /." Araraquara, 2016. http://hdl.handle.net/11449/148693.
Full textAbstract:
Orientador: Carlos Eduardo VerganiResumo: Esta presente tese foi dividida em quatro estudos que tiveram como objetivos. 1. Validar um protocolo e comparar o efeito dos tampões RPMI/MOPS e RPMI/HEPES no desenvolvimento de biofilmes e na viabilidade celular de queratinócitos (NOK-si e HaCat); 2. Comparar o dano celular e a resposta inflamatória induzidos pelos metabólitos de biofilmes simples e misto de Staphylococcus aureus e Candida albicans; 3. Avaliar o tipo de morte celular (apoptose vs. necrose) e a ativação de caspases relacionadas aos metabólitos desses biofilmes e 4. Caracterizar um tecido oral reconstituído e analisar o dano tecidual causado pelo sobrenadante e biofilme propriamente dito desses microrganismos. No estudo 1, a viabilidade celular foi avaliada pelo método colorimétrico do MTT e por imagens da cultura após 12 horas em contato com os meios de cultura. Ambos os tampões permitiram similar crescimento do biofilme. Efeito citotóxico do MOPS foi verificado após 6 horas de crescimento de NOK-si e HaCat. Houve preservação da viabilidade e morfologia quando as células foram expostas a RPMI/HEPES. Conclui-se que RPMI/HEPES pode ser utilizado como um meio tamponamente viável para estudos que avaliam o efeito do biofilme em cultura de queratinócitos ao longo do tempo. No estudo 2, o sobrenadante dos biofilmes de 36 h de C. albicans e S. aureus, isolados ou em associação, foi colocado em contato com NOK-si, HaCat e macrófagos (J774A.1). O dano celular foi avaliado por meio de ensaios de viabilidade celular ... (Resumo completo, clicar acesso eletrônico abaixo)
The present thesis was divided into four studies with the following objectives. 1. Validate a protocol and compare the effect of RPMI/MOPS and RPMI/HEPES buffers on the development of biofilms and keratinocyte cell viability (NOK-si and HaCat); 2. Compare the cellular damage and the inflammatory response induced by the metabolites of simple and mixed biofilms of Staphylococcus aureus and Candida albicans; 3. Evaluate the type of cell death (apoptosis vs. necrosis) and the activation of caspases related to the metabolites of these biofilms and 4. Characterize the reconstituted oral tissue and analyze the tissue damage caused by the supernatant and biofilm of these microorganisms. In study 1, cell viability was evaluated by the MTT colorimetric method and by culture images after 12 hours in contact with the culture media. Both buffers permitted similar biofilm growth. The cytotoxic effect of MOPS was observed after six hours of NOK-si and HaCat growth. There was preservation of viability and morphology when cells were exposed to RPMI/HEPES. It was concluded that RPMI/HEPES can be used as a buffering medium for studies evaluating the effect of biofilm on keratinocyte culture over time. In study 2, the supernatant of the 36-hour biofilms of C. albicans and S. aureus, isolated or in combination, was placed in contact with NOK-si, HaCat and macrophages (J774A.1). Cell damage was assessed by cell viability assays (MTT) and LDH enzyme release. Cytokine production was analyzed by the ELISA method and evaluation of the type of cell death by the staining of the apoptotic cells with annexin V and the necrotic cells with propidium iodide. The mixed biofilm and biofilm of C. albicans were more cytotoxic, and the mixed biofilm caused greater cellular damage through the release of the LDH enzyme. S. aureus biofilm metabolites stimulated greater production of NO, IL-6 and TNF-α... (Complete abstract electronic access below)
Doutor
6
Probert, Hollie Marie. "An investigation of the lumenal and mucosal microflora of the human colon : effects of prebiotics on bacteriology and gas generation." Thesis, University of Reading, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.252247.
Full text
7
Gavrilko, Oleg. "Avaliação do perfil microbiológico e de suscetibilidade antimicrobiana de bactérias da mucosa bucal e o biofilme dental após o uso de solução de clorexidina em pacientes sob ventilação mecânica." reponame:Repositório Institucional da UFPR, 2016. http://hdl.handle.net/1884/44686.
Full textAbstract:
Orientador: Prof. Dr. Felipe Francisco TuonCoorientador: Prof. Dr. Edvaldo Rosa
Tese (doutorado) - Universidade Federal do Paraná, Setor de Ciências da Saúde, Programa de Pós-Graduação em Medicina Interna. Defesa : Curitiba, 25/08/2016
Inclui referências : f. 28-35;58-59
Resumo: A mudança na microbiota do biofilme dental após o uso de solução de clorexidina (CHX) oral em pacientes sob ventilação mecânica não foi descrita. Objetivo: O objetivo deste estudo foi avaliar a presença de bactérias patogênicas associadas a PAVM (pneumonia associada a ventilação mecânica) em mucosa bucal (OM) e da placa dentária (DP) em pacientes em uso de solução de CHX. Métodos: Um estudo randomizado, controlado, estudo prospectivo, duplo-cego. Pacientes submetidos à ventilação mecânica foram randomizados para a higiene bucal com CHX ou placebo. Amostras clínicas foram coletadas de OM e DP após a admissão e, em seguida, nos dias 3, 5, 7 e 10. A determinação da concentração inibitória mínima de clorexidina e concentração bactericida mínima foram realizadas. Resultados: 16 pacientes foram incluídos. No dia 5, todos os pacientes tiveram culturas positivas para OM e DP. No momento da admissão, 6 pacientes tiveram bactérias multirresistentes, incluindo uma Klebsiella pneumoniae carbapenemresistente. O grupo CHX teve uma menor percentagem de MRSA que no grupo placebo em OM [RR = 0,51 (0,27-0,98), p = 0,011]. Houve alta concordância de culturas entre OM e DP (índice de kappa = 0,825). PAVM ocorreu em 6 pacientes e as espécies identificadas na aspiração traqueal de pacientes PAVM foram semelhantes aos encontrados no OM em 4 casos. Todas as cepas apresentaram baixa MIC e MBC para CHX (<0,039 mg / mL). Conclusão: DP é rapidamente colonizado por bactérias multirresistentes e que a solução de CHX a 2% reduziu a colonização por Staphylococcus aureus. Palavras chave: pneumonia associada à ventilação mecânica; clorexidina; microbiota bucal; unidade de terapia intensiva.
Abstract: The change in dental plaque microbiota following chlorhexidine (CHX) use in patients under mechanical ventilation has not been described. Objective: The aim of this study is to evaluate the presence of pathogenic bacteria associated with VAP (ventilator associated pneumonia) in oral mucosa(OM) and dental plaque(DP) in patients using chlorhexidine. Methods: A prospective, randomized, controlled, double-blind study. Patients submitted to mechanical ventilation were randomized for oral hygiene with CHX or placebo. Microbiology samples were collected from OM and DP after admission and then on days 3, 5, 7 and 10. Determination of chlorhexidine minimal inhibitory concentration and minimal bactericidal concentration were performed. Results: 16 patients were included. In day 5, all patients had positive cultures for OM and DP. Upon admission, 6 patients had multidrug-resistant bacteria, including a carbapenem-resistant Klebsiella pneumoniae. The CHX group had a lower percentage of MRSA than placebo group in OM [RR=0.51(0.27-0.98), p=0.011]. There was a high concordance of cultures between OM and DP (kappa index=0.825). VAP occurred in 6 patients and the species identified in tracheal aspiration of VAP patients were similar to those found in the OM in 4 cases. All strains showed low MIC and MBC for CHX (<0.039 mg/mL). Conclusion: DP is rapidly colonized with multidrug-resistant bacteria and that 2% chlorhexidine reduced colonization by Staphylococcus aureus.
8
Costa, José Pedro Soares da. "Lesões orais associadas ao uso de próteses removíveis." Master's thesis, [s.n.], 2014. http://hdl.handle.net/10284/4454.
Full text
9
Singhal, Deepti. "Bacterial & fungal biofilms in chronic rhinosinusitis." Thesis, 2011. http://hdl.handle.net/2440/72282.
Full textAbstract:
Chronic Rhinosinusitis (CRS) is a recalcitrant disease, characterized by headache, nasal discharge / blockage, which substantially impairs daily functioning and negatively affect quality of life. Endoscopic Sinus Surgery (ESS) is an important treatment option for CRS, but has variable success rates. Biofilms are well organised heterogeneous communities of microbes embedded in a mosaic of extracellular matrix, adherent to biotic / abiotic surfaces. As they are resistant to host defences and medical treatments, they have been touted as possible pathogenic factors in CRS, which may perpetuate the recurrent and recalcitrant character of the disease and negatively affect treatment outcomes. This thesis encompasses research undertaken to enhance our understanding about the effect that presence and types of biofilms have on the clinical profile and treatment outcomes of patients suffering with chronic rhinosinusitis. An in-vitro model of fungal biofilms and a potential tool to assay in-vivo mucosal biofilms on sinonasal tissues has also been described. Chapter 1 of the thesis comprehensively reviews the scientific literature pertaining to biofilms and CRS, and exhaustively evaluates the evidence present in relation to bacterial and fungal biofilms in CRS.
Chapter 2 describes a study to investigate the effect of biofilms on outcomes following ESS in CRS patients using internationally accepted standardised symptom scores, quality of life measures and endoscopy scores to assess the disease. It showed that patients with biofilms presented with more severe disease before surgery, and after surgery had persistent symptoms, ongoing mucosal inflammation and infections necessitating extra post-operative visits and multiple antibiotic treatments. This study thus strengthened the evidence for the role that biofilms may play in recalcitrant CRS.
Chapter 3 describes a further subgroup analysis of the above patients in whom the specific organisms forming the biofilms were identified and how patients with specific biofilm types progressed after surgery was studied. Patients with polymicrobial biofilms suffered more severe disease and had worse post-surgery mucosal outcomes requiring more post–operative visits. S.aureus biofilms played a dominant role in negatively affecting outcomes of ESS with persisting post-operative symptoms, ongoing mucosal inflammation and infections.
Chapter 4 describes an in-vitro model characterizing A. fumigatus biofilm formation on primary human sinonasal epithelium cultures under different growth conditions. 3-dimensional biofilm structures with parallel-packed and cross-linked hyphae, channels/passages, extracellular matrix (ECM) encasing the hyphae, were formed. Biofilms formed under flow conditions displayed more robust and faster growth kinetics as compared to those under static conditions, with extensive ECM production.
Chapter 5 investigates application of an analysis program ‘COMSTAT 2’ for assaying & quantitatively describing the 3-dimensional in-vivo biofilm structures observed via confocal scanning microscopy on sino-nasal mucosal samples. This can be used for temporal analysis of biofilm development, comparison of different types of biofilms formed under controlled conditions, analysis of influence of varying environmental factors on biofilms and the efficacy of different antibiofilm treatments.
Chapter 6 summarises and discusses the salient features of the studies included in this thesis which has attempted to characterize fungal and bacterial biofilms and the impact they may have in CRS patients.Thesis (Ph.D.) -- University of Adelaide, School of Medicine, 2011
Books on the topic "Mucosal biofilms"
1
Hube, Bernhard, and Oliver Kurzai. Candida species. Edited by Christopher C. Kibbler, Richard Barton, Neil A. R. Gow, Susan Howell, Donna M. MacCallum, and Rohini J. Manuel. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780198755388.003.0011.
Full textAbstract:
Most pathogenic Candida species are members of the microbiota, but also cause superficial or invasive infections. C. albicans is predominant, followed by C. glabrata, C. parapsilosis, and C. tropicalis. C. albicans is polymorphic and grows as yeast, pseudohyphae, or hyphae. The cell wall has multiple functions in pathogenesis. Metabolism and nutrient up-take strategies facilitate growth in multiple niches within the host. Drug resistance is an intrinsic property of C. glabrata and C. krusei, but can be developed by C. albicans and other Candida species during antifungal therapy. Pathogenicity mechanisms include host cell attachment, invasion, and destructive activities; immune evasion; and biofilm production. A disbalanced microbiota and impaired immunity favour superficial infections, and disturbance of the mucosal barriers, together with compromised immunity, enables Candida to invade the human bloodstream and cause invasive infection. Even with antifungal therapy (e.g. azoles or echinocandins), disseminated candidiasis has a high mortality (40–50%).
Book chapters on the topic "Mucosal biofilms"
1
Negrini, Thais de Cássia, Hyun Koo, and Rodrigo Alex Arthur. "Candida–Bacterial Biofilms and Host–Microbe Interactions in Oral Diseases." In Oral Mucosal Immunity and Microbiome, 119–41. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-030-28524-1_10.
Full text
2
Calò, L., G. C. Passàli, J. Galli, G. Fadda, and G. Paludetti. "Role of Biofilms in Chronic Inflammatory Diseases of the Upper Airways." In Recent Advances in Tonsils and Mucosal Barriers of the Upper Airways, 93–96. Basel: KARGER, 2011. http://dx.doi.org/10.1159/000324622.
Full text
3
Stickler, David J. "Polymicrobial Bacteriuria: Biofilm Formation on Foreign Bodies and Colonization of the Urinary Tract." In Colonization of Mucosal Surfaces, 409–29. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555817619.ch27.
Full text
4
Przybyłowska, D., E. Mierzwińska-Nastalska, R. Rubinsztajn, R. Chazan, D. Rolski, and E. Swoboda-Kopeć. "Influence of Denture Plaque Biofilm on Oral Mucosal Membrane in Patients with Chronic Obstructive Pulmonary Disease." In Advances in Experimental Medicine and Biology, 25–30. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/5584_2014_42.
Full text
5
Nistico, Laura, Armin Gieseke, Paul Stoodley, Luanne Hall-Stoodley, Joseph E. Kerschner, and Garth D. Ehrlich. "Fluorescence “In Situ” Hybridization for the Detection of Biofilm in the Middle Ear and Upper Respiratory Tract Mucosa." In Methods in Molecular Biology, 191–213. Totowa, NJ: Humana Press, 2009. http://dx.doi.org/10.1007/978-1-59745-523-7_12.
Full text
6
Venkiteswaran, Nityasri, Kassapa Ellepola, Chaminda Seneviratne, Yuan Lee, Kia Puan, and Siew Wong. "Host–Biofilm Interactions at Mucosal Surfaces and Implications in Human Health." In Microbial Biofilms, 203–36. Routledge, 2017. http://dx.doi.org/10.1201/9781315120119-10.
Full text
7
Macfarlane, S., and G. T. Macfarlane. "Bacterial Growth on Mucosal Surfaces and Biofilms in the Large Bowel." In Medical Implications of Biofilms, 262–86. Cambridge University Press, 2003. http://dx.doi.org/10.1017/cbo9780511546297.013.
Full text
8
Ouwehand, Arthur C., Elina M. Tuomola, Yuan Kun Lee, and Seppo Salminen. "[13] Microbial interactions to intestinal mucosal models." In Microbial Growth in Biofilms - Part B: Special Environments and Physicochemical Aspects, 200–212. Elsevier, 2001. http://dx.doi.org/10.1016/s0076-6879(01)37015-5.
Full text
9
Hussain, Ahtesham, AbuZar Ansari, and Rizwan Ahmad. "Microbial biofilms: Human mucosa and intestinal microbiota." In New and Future Developments in Microbial Biotechnology and Bioengineering: Microbial Biofilms, 47–60. Elsevier, 2020. http://dx.doi.org/10.1016/b978-0-444-64279-0.00004-9.
Full text
10
Macfarlane, Sandra, Bahram Bahrami, and George T. Macfarlane. "Mucosal Biofilm Communities in the Human Intestinal Tract." In Advances in Applied Microbiology, 111–43. Elsevier, 2011. http://dx.doi.org/10.1016/b978-0-12-387046-9.00005-0.
Full textConference papers on the topic "Mucosal biofilms"
1
Armijo, Leisha M., Michael Kopciuch, Zuzia Olszόwka, Stephen J. Wawrzyniec, Antonio C. Rivera, John B. Plumley, Nathaniel C. Cook, et al. "Delivery of tobramycin coupled to iron oxide nanoparticles across the biofilm of mucoidal Pseudonomas aeruginosa and investigation of its efficacy." In SPIE BiOS, edited by Wolfgang J. Parak, Marek Osinski, and Kenji I. Yamamoto. SPIE, 2014. http://dx.doi.org/10.1117/12.2043340.
Full text